Moderate to Severe Plaque Psoriasis
Immunology·MeSH: Psoriasis
7 drugs in development·5 companies·3 clinical trials
Drug Pipeline by Phase
Approved(5)
Phase 3(1)
| Drug | Company |
|---|---|
| ustekinumab | POINT Biopharma Global Inc. (PNT) |
Phase 2(1)
| Drug | Company |
|---|---|
| bimekizumab | POINT Biopharma Global Inc. (PNT) |
Compare drugs
Frequently asked questions
How many drugs are in development for Moderate to Severe Plaque Psoriasis?
BioSniper tracks 7 drugs in development for Moderate to Severe Plaque Psoriasis across 5 companies.
How many clinical trials target Moderate to Severe Plaque Psoriasis?
There are 3 clinical trials targeting Moderate to Severe Plaque Psoriasis tracked by BioSniper.
Deep-dive into Moderate to Severe Plaque Psoriasis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis